Head of Novartis Oncology gives an insider view on drug development; warns that as therapies help cancer patients live longer, long-term care will fall to family physicians
Two studies from Duke University are suggesting a way to identify those at risk for postoperative delirium, which generally affects 15% of surgical patients.